Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model
- PMID: 27864074
- DOI: 10.1016/j.antiviral.2016.11.008
Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model
Abstract
The Enterovirus A71 (EV-A71) subgenogroup C4 is prevalent in China. EV-A71 causes hand, foot and mouth disease (HFMD) in children and may lead to severe neurological diseases. The development of antiviral and protective vaccines against EV-A71 is significantly hindered by the lack of suitable animal models to recapitulate human neurological symptoms. In this study, GZ-CII, a highly virulent EV-A71 subgenogroup C4 strain, was isolated from hospitalized children with HFMD. Intraperitoneal infections of GZ-CII resulted in progressive neurological disease in mice as old as 14 days. Administration of an inactivated EV-A71 vaccine or an anti-EV-A71 immune serum protected the mice against the GZ-CII infection. This demonstrated that a mouse model with EV-A71 GZ-CII could be used to evaluate potential vaccine candidates and therapeutics for subgenogroup C4. Comparing the genome sequence of GZ-CII with that of the avirulent EV-A71 subgenogroup C4 strain revealed unique mutations in GZ-CII. When mutation VP2-K149I was introduced into the nonpathogenic EV-A71 subgenogroup C4 strain, the variant similar to GZ-CII significantly increased viral replication and virulence in mice. These results indicated that the VP2-K149I mutation played an important role in enhancing the virulence of the EV-A71 subgenogroup C4 strain in mice, and that mice infected with the GZ-CII strain are a promising model for evaluating vaccines and therapeutics against the EV-A71 subgenogroup C4.
Keywords: Enterovirus A71 (EV-A71); Mouse infection model; Primary isolate; Vaccine.
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.J Virol. 2019 Jun 14;93(13):e02308-18. doi: 10.1128/JVI.02308-18. Print 2019 Jul 1. J Virol. 2019. PMID: 30996087 Free PMC article.
-
Virulence of Enterovirus A71 Fluctuates Depending on the Phylogenetic Clade Formed in the Epidemic Year and Epidemic Region.J Virol. 2021 Nov 9;95(23):e0151521. doi: 10.1128/JVI.01515-21. Epub 2021 Sep 15. J Virol. 2021. PMID: 34523967 Free PMC article.
-
Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice.BMC Microbiol. 2015 Jul 15;15:139. doi: 10.1186/s12866-015-0474-9. BMC Microbiol. 2015. PMID: 26169371 Free PMC article.
-
EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.Emerg Microbes Infect. 2016 Jul 20;5(7):e75. doi: 10.1038/emi.2016.73. Emerg Microbes Infect. 2016. PMID: 27436364 Free PMC article. Review.
-
Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development.Rev Inst Med Trop Sao Paulo. 2018 Nov 8;60:e70. doi: 10.1590/S1678-9946201860070. Rev Inst Med Trop Sao Paulo. 2018. PMID: 30427405 Free PMC article. Review.
Cited by
-
Neurotropism In Vitro and Mouse Models of Severe and Mild Infection with Clinical Strains of Enterovirus 71.Viruses. 2017 Nov 20;9(11):351. doi: 10.3390/v9110351. Viruses. 2017. PMID: 29156632 Free PMC article.
-
A Single Mutation in the VP1 Gene of Enterovirus 71 Enhances Viral Binding to Heparan Sulfate and Impairs Viral Pathogenicity in Mice.Viruses. 2020 Aug 13;12(8):883. doi: 10.3390/v12080883. Viruses. 2020. PMID: 32823486 Free PMC article.
-
A Single Amino Acid Substitution in Structural Protein VP2 Abrogates the Neurotropism of Enterovirus A-71 in Mice.Front Microbiol. 2022 Mar 17;13:821976. doi: 10.3389/fmicb.2022.821976. eCollection 2022. Front Microbiol. 2022. PMID: 35369482 Free PMC article.
-
A 10-Day-Old Murine Model of Coxsackievirus A6 Infection for the Evaluation of Vaccines and Antiviral Drugs.Front Immunol. 2021 May 13;12:665197. doi: 10.3389/fimmu.2021.665197. eCollection 2021. Front Immunol. 2021. PMID: 34054834 Free PMC article.
-
EV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production.PLoS Pathog. 2019 Nov 15;15(11):e1008142. doi: 10.1371/journal.ppat.1008142. eCollection 2019 Nov. PLoS Pathog. 2019. PMID: 31730654 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous